These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2973369)

  • 1. Two partial remissions induced by an LHRH analogue in two postmenopausal women with metastatic breast cancer.
    Schwartz L; Guiochet N; Keiling R
    Cancer; 1988 Dec; 62(12):2498-500. PubMed ID: 2973369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with a luteinising-hormone-releasing-hormone analogue (buserelin) in premenopausal patients with metastatic breast cancer.
    Klijn JG; de Jong FH
    Lancet; 1982 May; 1(8283):1213-6. PubMed ID: 6122975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6-Pro9-NEt]LHRH increased rather than lowered LH and alpha-subunit levels in a patient with an LH-secreting pituitary tumor.
    Roman SH; Goldstein M; Kourides IA; Comite F; Bardin CW; Krieger DT
    J Clin Endocrinol Metab; 1984 Feb; 58(2):313-9. PubMed ID: 6198331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosis.
    Meldrum DR; Chang RJ; Lu J; Vale W; Rivier J; Judd HL
    J Clin Endocrinol Metab; 1982 May; 54(5):1081-3. PubMed ID: 6801075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.
    Roger M; Chaussain JL; Berlier P; Bost M; Canlorbe P; Colle M; Francois R; Garandeau P; Lahlou N; Morel Y
    J Clin Endocrinol Metab; 1986 Apr; 62(4):670-7. PubMed ID: 2936759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty.
    Crowley WF; Comite F; Vale W; Rivier J; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1981 Feb; 52(2):370-2. PubMed ID: 6780592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin-lowering effect of luteinizing hormone-releasing hormone agonist administration in prolactinoma patients.
    Rubio MA; Cabranes JA; Schally AV; Charro AL
    J Clin Endocrinol Metab; 1989 Aug; 69(2):444-7. PubMed ID: 2526819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable response to a long-acting agonist of luteinizing hormone-releasing hormone in girls with McCune-Albright syndrome.
    Foster CM; Comite F; Pescovitz OH; Ross JL; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1984 Oct; 59(4):801-5. PubMed ID: 6434582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressive effect of an inhibitory LHRH analog on the gonadotropin response to LHRH in normal women.
    Canales ES; Montvelinsky H; Zárate A; Kastin AJ; Coy DH; Schally AV
    Int J Fertil; 1980; 25(3):190-2. PubMed ID: 6108928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp6 analogue of luteinizing hormone-releasing hormone.
    Redding TW; Schally AV
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6509-12. PubMed ID: 6458815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D-Trp6-luteinizing hormone-releasing hormone inhibits sulpiride-induced hyperprolactinemia in normal men.
    Rubio MA; Torres-Aleman I; Calle JR; Cabranes JA; Schally AV; Charro AL
    J Clin Endocrinol Metab; 1987 Aug; 65(2):368-9. PubMed ID: 2954994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a new LH-RH analogue (D-Ser(TBU)6-EA10-LH-RH) on gonadotrophin and gonadal steroid secretion in men.
    Wiegelmann W; Solbach HG; Kley HK; Nieschlag E; Rudorff KH; Krüskemper HL
    Horm Res; 1976; 7(1):1-10. PubMed ID: 793974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gonadotropin and steroid secretory patterns during chronic treatment with a luteinizing hormone-releasing hormone agonist analog in men.
    Evans RM; Doelle GC; Alexander AN; Uderman HD; Rabin D
    J Clin Endocrinol Metab; 1984 May; 58(5):862-7. PubMed ID: 6423661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of precocious puberty with an LH-RH agonist (D-TRP6-LH-RH delayed-release microcapsules)].
    Canlorbe P; Chaussain JL; Lahlou N; Roger M; Toublanc JE; Job JC
    Bull Acad Natl Med; 1988 Nov; 172(8):1091-8. PubMed ID: 2977732
    [No Abstract]   [Full Text] [Related]  

  • 15. Direct actions of the luteinizing hormone-releasing hormone agonist, deslorelin, on anterior pituitary contents of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), LH and FSH subunit messenger ribonucleic acid, and plasma concentrations of LH and FSH in castrated male cattle.
    Aspden WJ; Rao A; Scott PT; Clarke IJ; Trigg TE; Walsh J; D'Occhio MJ
    Biol Reprod; 1996 Aug; 55(2):386-92. PubMed ID: 8828844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the luteinizing hormone-releasing hormone (LHRH) analog D-Trp6-Pro9-NEt-LHRH on the pituitary-gonadal axis of prepubertal rhesus monkeys.
    Cassorla F; Renquist D; Barnard D; Munabi AK; Cutler GB; Loriaux DL
    Biol Reprod; 1984 Jun; 30(5):1130-4. PubMed ID: 6428479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of thyrotropin-releasing hormone on the postmenopausal female.
    Lee SG; Lundy LE; Kashef M; Dorn J
    Obstet Gynecol; 1975 Jan; 45(1):25-6. PubMed ID: 803307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-Dopa effect on prolactin, follicle-stimulating hormone, and luteinizing hormone in women with advanced breast cancer: a preliminary report.
    Dickey RP; Minton JP
    Am J Obstet Gynecol; 1972 Sep; 114(2):267-9. PubMed ID: 4635766
    [No Abstract]   [Full Text] [Related]  

  • 19. Apparent absence of negative feedback in middle-aged persistent-estrous rats following luteinizing hormone-releasing hormone agonist treatment: relation to plasma inhibin and 17 beta-estradiol.
    Matt DW; Dahl KD; Sarkissian A; Sayles TE
    Biol Reprod; 1993 Feb; 48(2):333-9. PubMed ID: 8439622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to D-Trp-6-luteinising hormone releasing hormone (Decapeptyl) microcapsules in advanced ovarian cancer.
    Parmar H; Rustin G; Lightman SL; Phillips RH; Hanham IW; Schally AV
    Br Med J (Clin Res Ed); 1988 Apr; 296(6631):1229. PubMed ID: 2968130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.